Show simple item record

dc.contributor.authorCorkery, John M
dc.contributor.authorLoi, Barbara
dc.contributor.authorClaridge, Hugh
dc.contributor.authorGoodair, Christine
dc.contributor.authorSchifano, Fabrizio
dc.date.accessioned2019-10-11T00:12:37Z
dc.date.available2019-10-11T00:12:37Z
dc.date.issued2017-11-08
dc.identifier.citationCorkery , J M , Loi , B , Claridge , H , Goodair , C & Schifano , F 2017 , ' Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom communities associated with GHB and precursors ' , Current Drug Metabolism , vol. 19 , no. 12 , pp. 1086-1099 . https://doi.org/10.2174/1389200218666171108163817
dc.identifier.issn1389-2002
dc.identifier.urihttp://hdl.handle.net/2299/21731
dc.descriptionSubmitted 21 October 2016, Revised 5 May 2017, Accepted 8 October 2017, Published online 7 November 2017. Final prrofs and final version received 20 February 2019!!!!
dc.description.abstractBackground Misuse of gammahydroxybutrate (GHB) and its prodrugs gammabutyrolactone (GBL) and 1,4 butanediol (1,4-BD) has increased greatly since the early 1990s, particularly amongst lesbian, gay, bisexual and transgender (LGBT) individuals in recreational and sexual settings, e.g. 'chemsex'. Objective and method This paper presents an overview of GHB pharmacotoxicology and provides analyses of cases in the LGBT population associated with use of these substances extracted from the UK's National Programme on Substance Abuse Deaths database, to which notification is voluntary. Results From 1995 to September 2013, 21 GHB/GBL-associated fatalities were reported. None involved 1,4-BD. Typical victims were: Male (100%); White (67%), young (mean age 34 years); employed (90%); with a drug misuse history (81%). Most deaths were accidental (67%) or related to recreational drug use (19%), the remaining (potential) suicides. The majority of fatalities (83%) occurred in private residences, typically following recreational use; others occurred in specific 'gay'-oriented locales including clubs and saunas. Three London boroughs accounted for 62% of all notified deaths, reflecting the concentration of both resident and visiting 'gay' individuals. However, this may be an artefact of the voluntary nature of the data submission procedure in particular areas. GHB/GBL alone was implicated in 10% of fatalities. The following substances were implicated either alone or in combination in the remaining cases (percentages may add to more than 100%): cocaine (38%); alcohol (33%); amphetamines (29%); ecstasy (29%); diazepam (24%); ketamine (24%); mephedrone (24%). Post-mortem blood levels: mean 660 (range 22 - 2335; S.D. 726) mg/L. Conclusions Significant caution is needed when ingesting GHB/GBL, particularly with alcohol, benzodiazepines, stimulants, and ketamine. Risk of death is increased due to their CNS-depressant properties. Of these, 'chemsex' drugs such as cocaine, mephedrone and ketamine are of note. More awareness is needed in the 'gay' community about risks associated with the consumption of such substances.en
dc.format.extent14
dc.format.extent594734
dc.language.isoeng
dc.relation.ispartofCurrent Drug Metabolism
dc.subjectGHB
dc.subjectGBL
dc.subjectdeaths
dc.subjecttoxicity
dc.subjectLGBT community
dc.subjectUnited Kingdom (UK)
dc.titleDeaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom communities associated with GHB and precursorsen
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.description.statusPeer reviewed
dc.date.embargoedUntil2018-11-08
rioxxterms.versionofrecord10.2174/1389200218666171108163817
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record